Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avidity Biosciences, Inc.

25.58
+1.476.10%
Pre-market: 25.01-0.5700-2.23%04:20 EDT
Volume:1.55M
Turnover:39.15M
Market Cap:3.08B
PE:-8.86
High:25.80
Open:24.04
Low:23.66
Close:24.11
Loading ...

Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic

Benzinga
·
04 Jan

Why Is Avidity Biosciences, Inc. (RNA) Among the Best Multibagger Stocks to Buy Right Now?

Insider Monkey
·
02 Jan

Covid RNA Analyzed With Tee on OVM: Open (Incl. RSS3) Supercharges DeSci

TIPRANKS
·
31 Dec 2024

Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA

GlobeNewswire
·
31 Dec 2024

Veritas In Silico's RNA Function Control Patent Gains European Recognition

MT Newswires Live
·
30 Dec 2024

Veritas In Silico Secures European Patent for RNA Discovery

TIPRANKS
·
30 Dec 2024

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PR Newswire
·
21 Dec 2024

HC Wainwright Initiates Coverage on Avidity Biosciences With Buy Rating, $72 Price Target

MT Newswires Live
·
20 Dec 2024

Avidity Biosciences initiated with a Buy at H.C. Wainwright

TIPRANKS
·
20 Dec 2024

Avidity Biosciences Inc : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $72

THOMSON REUTERS
·
20 Dec 2024

Avidity Biosciences CEO Boyce sells 31,855 common shares

TIPRANKS
·
20 Dec 2024

Circio Secures Funding to Boost RNA Technology Development

TIPRANKS
·
19 Dec 2024

Jefferies healthcare analyst holds an analyst/industry conference call

TIPRANKS
·
19 Dec 2024

Circio Holding ASA Pioneers RNA Technology and Cancer Vaccine

TIPRANKS
·
17 Dec 2024

Avidity Biosciences (RNA) Receives a Buy from TD Cowen

TIPRANKS
·
13 Dec 2024

Theratechnologies Secures Canadian Rights for Ionis RNA Medicines

TIPRANKS
·
13 Dec 2024

ProQR’s Promising RNA-Editing Advancements and Strategic Collaborations Drive Buy Rating

TIPRANKS
·
12 Dec 2024

Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

GlobeNewswire
·
12 Dec 2024

ProQR Therapeutics Advances Axiomer RNA-Editing Platform with Strategic Partnerships

TIPRANKS
·
12 Dec 2024

Arrowhead announces interim results from ARO-CFB study

TIPRANKS
·
11 Dec 2024